GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (OSTO:LIPI) » Definitions » ROE % Adjusted to Book Value

Lipidor AB (OSTO:LIPI) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lipidor AB ROE % Adjusted to Book Value?

Lipidor AB's ROE % for the quarter that ended in Dec. 2024 was 0.00%. Lipidor AB's PB Ratio for the quarter that ended in Dec. 2024 was 23.67. Lipidor AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 0.00%.


Lipidor AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Lipidor AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipidor AB ROE % Adjusted to Book Value Chart

Lipidor AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -5.95 -7.18 -18.07 - -

Lipidor AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - Negative Equity -293.67 -

Competitive Comparison of Lipidor AB's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, Lipidor AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipidor AB's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lipidor AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Lipidor AB's ROE % Adjusted to Book Value falls into.



Lipidor AB ROE % Adjusted to Book Value Calculation

Lipidor AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 23.67
=0.00%

Lipidor AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 23.67
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lipidor AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Lipidor AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipidor AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16
Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Lipidor AB Headlines

No Headlines